Tag archives: EUA

COVID-19 Update: FDA revokes EUA for malaria drugs used as COVID-19 treatment

On June 15, 2020, the U.S. Food and Drug Administration (FDA) revoked emergency use authorization (EUA) for chloroquine (CQ) and hydroxychloroquine (HCQ). The FDA found that the criteria for issuance of the EUA are no longer met and “in light of ongoing reports of serious cardiac adverse events and several newly reported cases of methemoglobinemia … Continue reading

COVID-19 Update: CDC Issues Guidance on Decontamination of FFR and President Trump Issues Executive Orders for Medical Equipment

By Yvonne Puig (US), Daphne Calderon (US) and Jeff Wurzburg (US) on April 3, 2020 Posted in Coronavirus, General, News from DC, Regulatory

Earlier this week the U.S. Centers for Disease Control (CDC) provided recommendations for the decontamination and reuse of filtering facepiece respirators (FFR). The guidance states that a study found the coronavirus is able to survive for up to 72 hours on plastic, stainless steel, and cardboard. The CDC provides that “decontamination and subsequent reuse of … Continue reading